Working… Menu

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02395978
Recruitment Status : Completed
First Posted : March 24, 2015
Last Update Posted : November 25, 2019
Information provided by (Responsible Party):
BioLite, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 10, 2019
Actual Study Completion Date : September 30, 2019